CRGC Reporting Advisory 
December 16, 2015
 Coding Rituzimab (Rituxan) 
As a reminder, per the January 2013 update of SEER*Rx, the drug, Rituximab, (Rituxan) changed categories. For cases diagnosed prior to January 1, 2013, code Rituximab (Rituxan) as chemotherapy. Effective with diagnosis date January 1, 2013 forward, code Rituximab (Rituxan) as BRM/Immunotherapy. This was the result of a comprehensive review and in collaboration with the FDA.
If you have questions or concerns regarding any of the content of this CRGC Reporting Advisory please contact me .   

Mignon Dryden, CTR
Director, E-Reporting
Cancer Registry of Greater California